Natural Products with Anticancer Activity
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 25 April 2026 | Viewed by 79
Special Issue Editor
Interests: pharmacognosy; natural product chemistry; natural product pharmacology; bioactivity; ethnopharmacy; spectrometry; natural compounds; extraction; chromatography
Special Issue Information
Dear Colleagues,
Cancer continues to pose a significant challenge despite the availability of different therapeutic options. The development of multidrug resistance (MDR) is one of the major challenges in the successful treatment of cancer and continues to be a major obstacle to successful cancer chemotherapy. Over the years, drugs of natural origin have greatly contributed to cancer chemotherapy, e.g., paclitaxel, vincristine, and vinblastine. Plants and other natural sources can provide a huge range of complex and structurally diverse compounds, making them a great source for novel chemotherapeutics.
This Special Issue on “Natural Products with Anticancer Activity” will contribute to the development of new anticancer therapies and is, therefore, aimed at bringing together original research papers and review articles on the cytotoxic activity of natural products. Papers about different anticancer activities and mechanisms of action, be it in vitro, in vivo, or in silico studies of extracts, and/or their bioactive components, are welcome to be submitted to this Special Issue.
Many molecules of natural origin act as starting compounds for the synthesis of new molecules with cytotoxic effects; hence, articles on the anticancer activity of hemi-synthetic molecules of natural origin are also welcomed.
Dr. Epole Ntungwe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- extracts
- anticancer activities
- phytochemicals
- molecular mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
